CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Unrecognized Tax Benefits that Would Impact Effective Tax Rate
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) had Unrecognized Tax Benefits that Would Impact Effective Tax Rate of $153.30 million as of 2026-06-27, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate · last filed 2026-08-05
- 2026-06-27: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $153.30M.
- 2026-03-28: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $153.20M.
- 2025-12-27: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $21.80M.
- 2025-09-27: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $25.00M.
| Period end | Unrecognized Tax Benefits that Would Impact Effective Tax Rate | Unrecognized Tax Benefits that Would Impact Effective Tax Rate as first filed |
|---|---|---|
| 2026-06-27 | $153.30M 10-Q · filed 2026-08-05 | |
| 2026-03-28 | $153.20M 10-Q · filed 2026-05-07 | |
| 2025-12-27 | $21.80M 10-K · filed 2026-02-18 | |
| 2025-09-27 | $25.00M 10-Q · filed 2025-11-05 | |
| 2025-06-28 | $24.20M 10-Q · filed 2025-08-06 | |
| 2025-03-29 | $22.90M 10-Q · filed 2025-05-07 | |
| 2024-12-28 | $22.00M 10-K · filed 2026-02-18 | |
| 2024-09-28 | $22.10M 10-Q · filed 2024-11-06 | |
| 2024-06-29 | $21.10M 10-Q · filed 2024-08-07 | |
| 2024-03-30 | $20.70M 10-Q · filed 2024-05-09 | |
| 2023-12-30 | $20.30M 10-K · filed 2025-02-19 | |
| 2023-09-30 | $22.40M 10-Q · filed 2023-11-08 | |
| 2023-07-01 | $21.80M 10-Q · filed 2023-08-09 | |
| 2023-04-01 | $21.20M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $20.30M 10-K · filed 2024-02-14 | |
| 2022-09-24 | $29.60M 10-Q · filed 2022-11-02 | |
| 2022-06-25 | $31.10M 10-Q · filed 2022-08-03 | |
| 2022-03-26 | $31.10M 10-Q · filed 2022-05-04 | |
| 2021-12-25 | $30.00M 10-K · filed 2023-02-22 | |
| 2021-09-25 | $25.80M 10-Q · filed 2021-11-03 | |
| 2021-06-26 | $24.60M 10-Q · filed 2021-08-04 | |
| 2020-12-26 | $22.60M 10-K · filed 2022-02-16 | |
| 2020-09-26 | $16.00M 10-Q · filed 2020-10-29 | |
| 2020-06-27 | $15.10M 10-Q · filed 2020-08-05 | |
| 2020-03-28 | $16.30M 10-Q · filed 2020-05-07 | |
| 2019-12-28 | $17.00M 10-K · filed 2021-02-17 | |
| 2019-09-28 | $16.60M 10-Q · filed 2019-11-06 | |
| 2019-06-29 | $22.70M 10-Q · filed 2019-07-31 | |
| 2019-03-30 | $18.10M 10-Q · filed 2019-05-07 | |
| 2018-12-29 | $17.60M 10-K · filed 2020-02-11 | |
| 2018-09-29 | $18.80M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $18.00M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $19.30M 10-Q · filed 2018-05-10 | |
| 2017-12-30 | $22.70M 10-K · filed 2019-02-13 | |
| 2017-09-30 | $23.20M 10-Q · filed 2017-11-09 | |
| 2017-07-01 | $22.90M 10-Q · filed 2017-08-09 | |
| 2017-04-01 | $22.20M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $21.40M 10-K · filed 2018-02-13 | |
| 2016-09-24 | $22.20M 10-Q · filed 2016-11-02 | |
| 2016-06-25 | $22.20M 10-Q · filed 2016-08-03 | |
| 2016-03-26 | $20.10M 10-Q · filed 2016-05-04 | |
| 2015-12-26 | $20.10M 10-K · filed 2017-02-14 | |
| 2015-09-26 | $18.70M 10-Q · filed 2015-11-04 | |
| 2015-06-27 | $20.10M 10-Q · filed 2015-07-30 | |
| 2015-03-28 | $20.50M 10-Q · filed 2015-04-30 | |
| 2014-12-27 | $32.30M 10-K · filed 2016-02-12 | |
| 2014-09-27 | $32.20M 10-Q · filed 2014-10-30 | |
| 2014-06-28 | $32.88M 10-Q · filed 2014-08-07 | |
| 2014-03-29 | $14.29M 10-Q · filed 2014-04-30 | |
| 2013-12-28 | $32.30M 10-K · filed 2015-02-17 | $17.01M 10-K · filed 2014-02-25 |
| 2013-09-28 | $17.27M 10-Q · filed 2013-10-30 | |
| 2013-06-29 | $25.90M 10-Q · filed 2013-07-31 | |
| 2013-03-30 | $26.01M 10-Q · filed 2013-05-08 | |
| 2012-12-29 | $17.01M 10-K · filed 2015-02-17 | $24.39M 10-K · filed 2013-02-27 |
| 2012-09-29 | $21.78M 10-Q · filed 2012-11-01 | |
| 2012-06-30 | $23.04M 10-Q · filed 2012-08-07 | |
| 2012-03-31 | $22.94M 10-Q · filed 2012-05-04 | |
| 2011-12-31 | $22.48M 10-K · filed 2013-02-27 | |
| 2011-09-24 | $22.18M 10-Q · filed 2011-11-02 | |
| 2011-06-25 | $29.91M 10-Q · filed 2011-08-03 | |
| 2010-12-25 | $28.46M 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |